(Re)defining biopharmaceutical.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 18612293.
- Also identified by DOI 10.1038/nbt0708-743.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Vested interests are redefining, rebranding and co-opting what is 'biopharmaceutical'. This is not just a matter of semantics-the core identity of the biotech industry and its products is at stake.
Medical subject headings
- Biopharmaceutics
- Drug Industry
- Terminology as Topic